Patents by Inventor William Howard Waugh

William Howard Waugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8658621
    Abstract: A means is provided to make the capsules of cirrhotic or fibrotic livers relatively impermeable to liver tissue fluid or lymph in humans or other mammals suffering from severe chronic ascites or refractory ascites by application of collodion. The means will be useful to decrease the need for liver and combined liver and kidney transplantations.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: February 25, 2014
    Inventor: William Howard Waugh
  • Publication number: 20110190225
    Abstract: A means is provided to make the capsules of cirrhotic or fibrotic livers relatively impermeable to liver tissue fluid or lymph in humans or other mammals suffering from severe chronic ascites or refractory ascites by application of collodion.
    Type: Application
    Filed: February 2, 2010
    Publication date: August 4, 2011
    Inventor: William Howard Waugh
  • Publication number: 20090137612
    Abstract: A method is provided for the prevention and treatment of selective progressive degeneration within the central nervous system caused by hydroxyl-free or ferryl-free radicals formed by Fenton-type catalyzed reactions between diffusible hydrogen peroxide and localized bivalent iron. The invention embodies unique pharmacologic composition for antioxidant protection by oral supplementation with hypoxanthine conjointly with either sodium L-ascorbate or L-ascorbic acid. The hypoxanthine is provided for its sodium-dependent intestinal absorption and transport for the systemic production of higher antioxidant and iron-chelating uric acid levels. Ascorbate is provided as potent antioxidant to raise body ascorbic acid levels concurrently and to protect against possible deleterious effect from nucleobase or other molecular injury induced by oxidized uric acid as urate anion free radical caused in the antioxidant action of the uric acid.
    Type: Application
    Filed: November 27, 2007
    Publication date: May 28, 2009
    Inventor: William Howard Waugh
  • Patent number: 6028107
    Abstract: This invention is a novel method in orthomolecular medicine to sustain favorable amounts of L-arginine efficiently within the human body for preservation of good health and amelioration of various disease states. The method provides administration of sizable amounts of L-citrulline as precursor substance for bioconversion to L-arginine in order to maintain greater blood plasma concentrations of L-arginine as potential substrate for various metabolic functions. The method is useful to increase the availability of substrate for nitric oxide production by constitutive nitric oxide synthases. Embodiments include uses of exogenous L-citrulline for more vasoprotection in sickle cell disease and atherosclerosis, more stability in circulating platelets, more relaxative smooth muscle tone during pregnancy and in achalasia, greater defense against restenosis after angioplasty, greater defense against oxidative stress, enhanced cell stores of creatine, and enhanced fertility in males with oligospermia.
    Type: Grant
    Filed: February 27, 1997
    Date of Patent: February 22, 2000
    Inventor: William Howard Waugh
  • Patent number: 5874471
    Abstract: This invention is a novel method in orthomolecular health to sustain favorable amounts of L-arginine efficiently within the human body for preservation of good health and amelioration of various disease states. The method provides administration of sizable amounts of L-citrulline as precursor substance for bioconversion to L-arginine in order to maintain greater blood plasma concentrations of L-arginine as potential substrate for various metabolic functions. The method is useful to increase the availability of substrate for nitric oxide production by constitutive nitric oxide synthases.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: February 23, 1999
    Inventor: William Howard Waugh